Article
Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma.
Yonsei medical journal - 31 Dec 2005
Choi Gwang-Seong, Lee Moon-Hee, Kim Soon-Ki, Kim Chul-Soo, Lee Hong-Sik, Im Moon-Whan, Kil Hye-Yun, Seong Do-Hwan, Lee Jong-Rok, Kim Woo-Chul, Lee Min-Geol, Song Sun U
Abstract excerpt
A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow-derived DCs for the treatment of pre-existing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
